Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid

The susceptibilities of clinical vancomycin-intermediate Staphylococcus aureus (VISA), heterogenous VISA, and laboratory-generated linezolid-resistant S. aureus strains to the new oxazolidinone AZD2563 were assessed by agar dilution MIC determination. All clinical strains were susceptible to linezol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Howe, Robin A., Wootton, Mandy, Noel, Alan R., Bowker, Karen E., Walsh, Timothy R., MacGowan, Alasdair P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2003
Materias:
Susceptibility
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC253812/
https://ncbi.nlm.nih.gov/pubmed/14576139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.11.3651-3652.2003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares